dabigatran versus warfarin for intracardiac thrombus (mainly left atrial appendage thrombus) in patients with nonvalvular atrial fibrillation or atrial flutter

Trial Profile

dabigatran versus warfarin for intracardiac thrombus (mainly left atrial appendage thrombus) in patients with nonvalvular atrial fibrillation or atrial flutter

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 May 2016

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Warfarin
  • Indications Atrial fibrillation; Atrial flutter; Stroke; Thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 May 2016 Status changed from recruiting to completed.
    • 11 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top